Compare CVS Health Corp (CVS) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Rigetti Computing Inc — how do they compare? CVS Health Corp trades at $95.08 (market cap $119.58B), while Rigetti Computing Inc trades at $18.26 (market cap $6.04B). The key difference: CVS Health Corp is far larger — about 19.8× Rigetti Computing Inc's market cap, and CVS Health Corp pays a 2.84% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals.
| CVS | RGTI | |
|---|---|---|
Market Cap | $119.58B | $6.04B |
Sector | Health | Technology |
52-Week High | $110.60 | $56.34 |
52-Week Low | $65.51 | $12.90 |
Enterprise Value | $181.93B | $5.65B |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $94.70, down 1.01% with strong technical support at $93-$91 levels. The company reported robust Q2 2026 earnings of $2.58 per share, beating estimates by 38%, while raising full-year guidance. Revenue growth accelerated to 7.3% year-over-year, driven by Aetna's recovery and retail strength. Analyst consensus remains overwhelmingly bullish with 84% buy ratings and a $115.90 price target representing 22% upside potential.
CVS presents compelling value with a 0.29 P/S ratio and positive earnings momentum, though net margins remain thin at 1.18%. Key risks include 2027 PBM pressure and healthcare regulatory changes. The stock's current technical weakness near support levels offers potential entry point for long-term investors seeking exposure to integrated healthcare services.
Rigetti Computing (RGTI) trades at $18.24, up 3.31% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth of 185% to $5.1 million, beating estimates, but posted a net loss of $0.05 per share, missing expectations. Despite negative profitability metrics, analyst consensus is strongly bullish with 85.7% buy ratings. Recent news highlights government backing and quantum computing advancements, though high spending and losses persist.
The outlook for RGTI hinges on its ability to scale revenue and achieve profitability amid intense competition. Investment opportunity lies in its strategic position in quantum computing and potential government funding, but risks include sustained cash burn, execution challenges, and market volatility. The stock remains speculative, suitable for risk-tolerant investors betting on long-term quantum adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
